S100A4 and diabetic kidney disease: EMT represents a fundamental pathological process in DKD, characterized by the dissolution of epithelial cell junctions via E-cadherin suppression and concomitant acquisition of mesenchymal markers such as α-smooth muscle actin (α-SMA), fibroblast-specific protein 1 (FSP1), fibronectin, and vimentin.